ABOUT THE SURVEY

Question

Now that the Natural Medicine Health Act has passed in Colorado,
how can we best attend to the influx of needs of the general public?

What is the baseline knowledge that everyone needs to have in order to engage with this new law safely and effectively?

How can we provide a strong foundation so that our community can flourish amidst this new law?

Context

Colorado is at a pivotal moment in its relationship with plant medicine. The Natural Medicine Health Act (Proposition 122) passed in Colorado on November 8th 2022. The NMHA is a state-wide initiative that regulates and decriminalizes natural medicines including psilocybin, ibogaine, DMT, and mescaline (not including peyote). This will revolutionize the relationship between plant medicine and the people of Colorado. This initiative is unique in that it creates a hybrid framework for state regulated use alongside protections for personal use.

The rest of the United States will be looking towards Colorado and Oregon as examples to learn from when it comes to policy reform in psychedelic legislation.

Problem

In the NMHA, the Regulated Access Program will expand on the wisdom of Oregon’s Measure 109 and receive an additional 2 years of advisorship through a council of Colorado-based subject matter experts before being implemented. Personal Use of these powerful plant medicines will become more accessible to the public without this additional consideration.

We have little adequate, quantifiable data around the grassroots psychedelic communities’ desires and needs regarding how this initiative ought to be implemented. We have examples of how to implement a regulated access model from Oregon, however, the personal use component of the initiative is completely novel. Furthermore, the grassroots community does not have visibility into the rooms with elected officials and policy makers and has little power in the decision-making process around implementation.

We at ALKEMI see an opportunity to center the protection of Coloradans who are most vulnerable and will need to rely on well-funded and well-resourced infrastructure to support this paradigm shifting drug policy reform. Our main concern is whether there is a plan in place to build the social infrastructure needed to hold the influx of inquiries, psychedelic tourism, and personal use explorations in the time that Colorado is waiting for the Regulated Access program to be implemented.

Solution

In order for the grassroots psychedelic community to (a) be in a position to influence and impact laws and regulations around the implementation of the NMHA and (b) be in a position to benefit from the NMHA, we need to collect the voices, needs, and desires of this community and amalgamate them into a robust and unique data set that will inform the implementation of the initiative. 

How it Works

The survey is split into two parts.

Part One helps us get to know you, your understanding of the NMHA, and should the initiative pass, what your hopes are for its implementation.

This part of the survey takes about 15 minutes and contains the most relevant questions to implementation.

You can stop here and submit your responses.

Part Two gets into statistical information about our community, groups within it and your relationship with plant medicines.

This helps us give shape and context to responses from Part One.

PROJECT Value

• Develop unique data set

• Gather real-time data on community needs and desires 

• Develop quantitative data around community education and information

• Develop road map for the implementation of the NMHA

• Amplify and organize community stakeholders

• Empower community members

• Creating solidarity within community 

• Inform future campaigns and messaging in other states 

• Establish a leading body in community consensus building 

Data Protection

All data is anonymous, no personally identifiable questions are being asked and you will not be providing any contact information.

The data will live on ALKEMI’s private server, meaning that only the ALKEMI team has access to the data. T

he raw data will never be shared.

A final report compiling and analyzing that data will be written by ALKEMI and shared publicly.

AUDIENCE

The following categories of our audience listed below include members of the LGBTQIA+ and BIPOC

• Future Facilitators

  (coaches, psychotherapists, psychologists, guides)

• Cultivators / Mycologists

• Indigenous Elders

• Religious Leaders

• Veterans

• Future Health Center Owners

• Training Program Directors

• Educators & Teachers

• Participants / Clients / Explorers 

Feel free to reach out to ALKEMI if you have any questions at contact@alkemi-consulting.org

The ALKEMI Team,
Jaz, Sovereign & David